SIGVARIS Launches New Compression Therapy Designed to Promote Diabetic Wellness
PEACHTREE CITY, GA (PRWEB) January 29, 2015 -- For patients with diabetes, finding the right socks and footwear can often be a challenge. SIGVARIS is taking steps to make it easier with a new compression therapy designed to provide maximum therapeutic relief for diabetic patients.
Uniquely constructed with patented drirelease® yarns and an embedded FreshGuard® technology treatment, SIGVARIS EVERSOFT DIABETIC SOCKS wick away moisture and prevent odor, thus reducing friction against the skin and lowering the risk of infection. Unlike many other diabetic socks on the market, EVERSOFT DIABETIC SOCKS provide 8-15mmHg of graduated compression that improves circulation. A SIGVARIS flat toe seam design minimizes irritation, and a stretchable top band further enhances wearing comfort.
“By creating the most innovative products with the finest textiles available, SIGVARIS has quickly become a trusted name in compression therapy for diabetic patients,” says David Rosenberg, Director of Marketing for SIGVARIS North America. “Patients who try EVERSOFT DIABETIC SOCKS will be taking steps to improve their overall health, well being and activity level.”
SIGVARIS first introduced diabetic patients to the health benefits of graduated compression therapy several years ago with the launch of the SIGVARIS DIABETIC COMPRESSION SOCKS, backed by a clinical study that outlined the many benefits. With the launch of the new EVERSOFT DIABETIC SOCKS, physicians will now be able to determine whether a patient needs a light (8-15mmHg) or a moderate (18-25mmHg) compression therapy level and be able to prescribe the SIGVARIS compression therapy that best suits the needs of each individual patient.
Socks and hosiery that feature graduated compression therapy are designed to be tightest at the ankle and decrease in pressure going up the legs. Graduated Compression garments help improve circulation and revive tired, achy legs. They also help with the treatment and prevention of chronic venous insufficiency and varicose veins. SIGVARIS offers three categories of products:
SIGVARIS MEDICAL, SIGVARIS WELL BEING and SIGVARIS SPORTS.
For more information about the EVERSOFT DIABETIC SOCKS or for tips about how to keep your legs healthy, visit http://www.sigvarisusa.com.
About SIGVARIS
SIGVARIS® North America is part of an internationally active medical device group headquartered in Winterthur, Switzerland that focuses on the development, production and distribution of medical compression garments, including hosiery and socks. With distribution in more than 60 countries on six continents, SIGVARIS is recognized as a global industry leader in the area of compression therapy for the management of chronic venous disorders. SIGVARIS product lines include: SIGVARIS MEDICAL, SIGVARIS WELL BEING and SIGVARIS SPORTS. Our U.S. manufacturing plant is located in Peachtree City, Ga. In 2014, SIGVARIS celebrated its 150th Anniversary. For more information, please visit http://www.sigvarisusa.com. SIGVARIS is a registered trademark of SIGVARIS AG, CH-9014 St. Gallen/Switzerland and in many countries worldwide.
Melissa Gwozdz, Sigvaris, Inc., http://www.sigvarisusa.com, +1 770-714-9828, [email protected]
Share this article